Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Influenza, Human × vaxigrip × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 1 Influenza, Human 1

Interventions

Influenza Vaccines 13 trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine 2 Vaccines 2 Oseltamivir 2 FluMist 2 Cyclophosphamide 2 vaxigrip 1 thymoglobulin 1 peginterferon alfa-2a 1 influvac 1 fludarabine 1 baloxavir 1 Starch 1 SARS-CoV-2 inactivated vaccines 1 Rituximab 1 Nivolumab 1 Melphalan 1 Levetiracetam 1 Lenalidomide 1 Ipilimumab 1 Interferons 1 Interferon alpha-2 1 Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Fluzone High-Dose 1 Diphtheria-Tetanus Vaccine 1 Celecoxib 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01707628 2014-01-31

Rituxivac

St. Antonius Hospital

Phase NA Completed

Influenza, Human, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡